Correlation between activation of the sympathetic nervous system estimated by plasma concentrations of norepinephrine and Doppler echocardiographic variables in dogs with acquired heart disease

American Journal of Veterinary Research

Volumn 67, Issue 7, 2006, Pages 1163-1168

  Marcondes Santos, Mário ^a,c   Strunz, Célia M C ^b   Larsson, Maria H M A ^a  

^a School of Veterinary Medicine and Animal Sciences   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Sena Madureira Veterinary Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN;

ADRENERGIC ACTIVITY; AORTA; ARTICLE; BLOOD SAMPLING; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DOG; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT ATRIUM; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; M MODE ECHOCARDIOGRAPHY; MALE; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; NONHUMAN; NORADRENALIN BLOOD LEVEL; PROGNOSIS;

ANIMALIA; CANIS FAMILIARIS;

EID: 33747595242     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.7.1163     Document Type: Article

References (44)

1. Levine TB, Francis GS, Goldsmith SR, et al. Activity of sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982;49:1659-1666.
2. Ware WA, Lund DD, Subieta AR, et al. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy. J Am Vet Med Assoc 1990;197:1475-1481.
3. Ware WA. Tratamento da insuficiência cardíaca congestiva. In: Nelson WR, Couto CG, eds. Fundamentos de medicina interna de pequenos animals. Rio de Janeiro: Guanabara Koogan, 1994;32-43.
4. Knight DH. Fisiopatologia da insuficiência cardíaca e avaliação clínica da função cardíaca. In: Ettinger SJ, Feldman EC, eds. Tratado de medicina interna veterinária. São Paulo, Brazil: Manole, 1997; 1185-1217.
5. Kittleson MD. Management of heart failure. In: Kittleson MD, Kienle RD, eds. Small animal cardiovascular medicine. St Louis: CV Mosby Co, 1998;216-250.
6. Hamlin RL. Pathophysiology of heart failure. In: Fox PR, Sisson D, Moïse NS, eds. Textbook of canine and feline cardiology: principles and clinical practice. 2nd ed. Philadelphia: WB Saunders Co, 1999;205-215.
7. Belerenian GC, Mucha CJ, Camacho AA. Manejo de la insuficiencia cardiaca congestiva. In: Belerenian GC, Mucha CJ, Camacho AA, eds. Afecciones cardiovasctilares en pequeños animales. Buenos Aires: Intermédica, 2001;103-107.
8. Abraham WT. Neurohormonal activation in heart failure: pathophysiologic and therapeutic implications, in Proceedings. 17th Meet Am Coll Vet Intern Med 1999;75-77.
9. Sisson D, Kittleson MD. Management of heart failure: principles of treatment, therapeutics strategies and pharmacology. In: Fox PR, Sisson D, Moïse NS, eds. Textbook of canine and feline cardiology: principles and clinical practice. 2nd ed. Philadelphia: WB Saunders Co, 1999;216-250.
10. Ishise H, Asanoi H, Ishizaka S, et al. Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J Appl Physiol 1998;84:1234-1241.
11. Sisson DD. Neuroendocrine evaluation of cardiac disease. Vet Clin North Am Small Anim Pract 2004;34:1105-1126.
12. Dorn GW. Adrenergic pathways and left ventricular remodeling. J Card Fail 2002;8(suppl 6):S370-S373.
13. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233-243.
14. Francis GS, Goldsmith SR, Cohn JN. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J 1982;104:725-731.
15. Bristow MR. The adrenergic nervous system in heart failure. N Engl J Med 1984;311:850-851.
16. Ross RD, Daniels SR, Schwartz DC, et al. Plasma norepinephrine levels in infants and children with congestive heart failure. Am J Cardiol 1987;59:911-914.
17. Rector TS, Olivari MT, Levine TB, et al. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am Heart J 1987;114:148-152.
18. Abraham WT, Hensen J, Schrier RW. Elevated plasma floradrenaline concentrations in patients with low-output cardiac failure: dependence on increased noradrenaline secretion rates. Clin Sci (Lond) 1990;79:429-435.
19. Patel MB, Stewart JM, Loud AV, et al. Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine. Circulation 1991;84:2091-2100.
20. Sato N, Vatner SF, Shen YT, et al. Effects on cardiac denervation on development of heart failure and catecholamine desensitization. Circulation 1997;95:2130-2140.
21. Houle MS, Billman GE. Low-frequency component of heart rate variability spectrum: a poor marker of sympathetic activity. Am J Physiol 1999;276:H215-H223.
22. Ohtsuka S, Suzuki S, Ishikawa K, et al. Norepinephrine release is increased in the hibernating heart, studied in a chronic model of myocardial hibernation. J Cardiovasc Pharmacol 2000;36(suppl 2):S35-S41.
23. Stewart JM, Patel MB, Wang J, et al. Chronic elevation of norepinephrine in conscious dogs produces hypertrophy with no loss of LV reserve. Am J Physiol 1992;262:H331-H339.
24. Mann DL, Kent RL, Parsons B, et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992;85:790-804.
25. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823.
26. Benedict CR, Shelton B, Johnstone DE, et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996;94:690-697.
27. Uechi M, Shimizu A, Mizuno M. Heart rate modulation by sympathetic nerves in dogs with heart failure. J Vet Med Sci 2002;64:1023-1029.
28. Bench Study Group. The effects of benazepril an survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol 1999;1:7-18.
29. Morais HA, Schwartz DS. Pathophysiology of heart failure. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. St Louis: Elsevier Saunders, 2005;935.
30. Bühler HU, da Prada M, Haefely W, et al. Plasma adrenaline, noradrenaline and dopamine in man and different animal species. J Physiol 1978;276:311-320.
31. Yui Y, Fujita T, Yamamoto T, et al. Liquid-chromatographic determination of norepinephrine and epinephrine in human plasma. Clin Chem 1980;26:194-196.
32. Krstulovic AM. Investigations of catecholamine metabolism using high-performance liquid chromatography. J Chromatogr 1982;229:1-34.
33. Davies CL, Molyneux SG. Routine determination of plasma catecholamines using reversed-phase ion-pair high-performance liquid chromatography with electrochemical detection. J Chromatogr 1982;231:41-51.
34. Bouloux P, Perrett D, Besser GM. Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection. Ann Clin Biochem 1985;22:194-203.
35. Thomas WP, Gaber CE, Jacobs GJ, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. J Vet Intern Med 1993;7:247-252.
36. Boon JA. The echocardiographic examination. In: Boon JA, ed. Manual of veterinary echocardiography. Baltimore: The Williams & Wilkins Co, 1998;151-260.
37. Moïse NS, Fox PR. Echocardiography and Doppler imaging. In: Fox PR, Sisson D, Moïse NS, eds. Textbook of canine and feline cardiology. 2nd ed. Philadelphia: WB Saunders Co, 1999;130-171.
38. Brown DJ, Rush JE, MacGregor J, et al. M-mode echocardiographic ratio indices in normal dogs, cats, and horses: a novel quantitative method. J Vet Intern Med 2003;17:653-662.
39. Fujii Y, Wakao Y. Spectral analysis of heart rate variability in dogs with mild mitral regurgitation. Am J Vet Res 2003;64:145-148.
40. Mehta RH, Supiano MA, Oral H, et al. Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation. Am Heart J 2003;145:1078-1085.
41. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
42. Bristow MR. Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 1997;80:26L-40L.
43. Häggström J, Kvart C, Pedersen, HD. Acquired valvular heart disease. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. St Louis: Elsevier Saunders, 2005;1022-1036.
44. Miller MW. Carvedilol and the heart: a promising therapy, in Proceedings. North Am Vet Conf 2005;125.